Skip to Main Content

Paper Details

Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424.
International Journal of Radiation Oncology Biology Physics
29
2020
Low-Grade Gliomas, TMZ, Temozolomide, astrocytoma, bihemispheric tumor, low-grade glioma, low-grade gliomas, patients, temozolomide
Author NameAffiliation
Stephanie L Pugh
C Leland RogersArizona Oncology Services Foundation
Minhee Won
Minesh P MehtaMiami Cancer Institute
  • 1 - 4

Datasets

Release 1.2